|
⚲
|
| Keyboard |
| Baker Bros Advisors GP LLC
✚
|
|
|---|---|
| CIK # | 0001580575 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001580575] | |
| 4 | [0001580575] | |
| 5 | [0001580575] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
DBV Technologies SA DBVT
BS Warrant · derivative
|
2026-01-12 | Option exercise | 25,005,240 | $0.00 | |
|
DBV Technologies SA DBVT
Second Pre-Funded Warrant · derivative
|
2026-01-12 | Option exercise | 2,299,656 | $0.00 | |
|
DBV Technologies SA DBVT
Second Pre-Funded Warrant · derivative
|
2026-01-12 | Option exercise | 25,005,240 | $0.00 | |
|
DBV Technologies SA DBVT
BS Warrant · derivative
|
2026-01-12 | Option exercise | 2,299,656 | $0.00 | |
|
Bicycle Therapeutics PLC BCYC
Share Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 38,000 | $0.00 | |
|
Bicycle Therapeutics PLC BCYC
Share Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 38,000 | $0.00 | |
|
Bicycle Therapeutics PLC BCYC
American Depositary Shares
|
2026-01-02 | Grant | 19,000 | $0.00 | |
|
Bicycle Therapeutics PLC BCYC
American Depositary Shares
|
2026-01-02 | Grant | 19,000 | $0.00 | |
|
Incyte Corp INCY
Common Stock
|
2025-12-31 | Grant | 328 | $0.00 | |
|
Incyte Corp INCY
Common Stock
|
2025-12-31 | Grant | 328 | $0.00 | |
|
Kodiak Sciences Inc KOD
Common Stock
|
2025-12-18 | Buy | 2,391,268 | $23.00 | 54,999,164 |
|
Kodiak Sciences Inc KOD
Common Stock
|
2025-12-18 | Buy | 217,428 | $23.00 | 5,000,844 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-12-11 | Buy | 1,838,621 | $86.00 | 158,121,406 |
|
Denali Therapeutics Inc DNLI
$0.01 Prefunded Warrants · derivative
|
2025-12-11 | Buy | 2,095,191 | $17.49 | 36,644,891 |
|
Denali Therapeutics Inc DNLI
$0.01 Prefunded Warrants · derivative
|
2025-12-11 | Buy | 190,523 | $17.49 | 3,332,247 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-12-11 | Buy | 167,192 | $86.00 | 14,378,512 |
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2025-11-20 | Buy | 13,386 | $9.07 | 121,411 |
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2025-11-20 | Buy | 1,213 | $9.07 | 11,002 |
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2025-11-20 | Buy | 1,186 | $9.07 | 10,757 |
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2025-11-20 | Buy | 13,082 | $9.07 | 118,654 |
| showing 20 of 200 most recent transactions | |||||